We assessed the efficacy of itraconazole as prophylaxis against serious fungal infections in chronic granulomatous disease. Thirty-nine patients at least 5 years old (6 female and 33 male ...

Between July 1, 2019, and Aug. 31, 2021, they randomly assigned 164 patients with chronic pulmonary aspergillosis who were naive to antifungal treatment to receive a starting dose of 400 mg per ...

May 13, 2003 — Itraconazole was better than fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant patients, according to the results of a randomized ...

Patients with neutropenia resulting from chemotherapy for acute myelogenous leukemia or the myelodysplastic syndrome are at high risk for difficult-to-treat and often fatal invasive fungal infections.

April 30, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn clinicians against using itraconazole in patients with evidence of left ventricular ...

Amphotericin B vs itraconazole for HIV-associated talaromycosis Treatment with amphotericin B was superior to itraconazole as an induction therapy for HIV-associated talaromycosis. Treatment with ...